La maladie de Parkinson au Canada (serveur d'exploration) - Exploration (Accueil)

Index « Titre (en) » - entrée « monoamine »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
mono < monoamine < monoamines  Facettes :

List of bibliographic references indexed by monoamine

Number of relevant bibliographic references: 30.
[0-20] [0 - 20][0 - 30][20-29][20-40]
Ident.Authors (with country if any)Title
000641 (2015) Philippe Huot [Canada] ; Susan H. Fox [Canada] ; Jonathan M. Brotchie [Canada]Monoamine Reuptake Inhibitors in Parkinson's Disease
000679 (2015) Kelly M. Lohr [États-Unis] ; Kristen A. Stout [États-Unis] ; Amy R. Dunn [États-Unis] ; Minzheng Wang [États-Unis] ; Ali Salahpour [Canada] ; Thomas S. Guillot [États-Unis] ; Gary W. Miller [États-Unis]Increased Vesicular Monoamine Transporter 2 (VMAT2; Slc18a2) Protects against Methamphetamine Toxicity
000A34 (2014) Kelly M. Lohr ; Alison I. Bernstein ; Kristen A. Stout ; Amy R. Dunn ; Carlos R. Lazo ; Shawn P. Alter ; Minzheng Wang ; Yingjie Li ; Xueliang Fan ; Ellen J. Hess ; Hong Yi ; Laura M. Vecchio [Canada] ; David S. Goldstein ; Thomas S. Guillot ; Ali Salahpour [Canada] ; Gary W. MillerIncreased vesicular monoamine transporter enhances dopamine release and opposes Parkinson disease-related neurodegeneration in vivo
000A53 (2014) Paraskevi Vivien Rekkas ; Alan A. Wilson ; Vivian Wai Han Lee ; Priyanga Yogalingam ; Julia Sacher ; Pablo Rusjan ; Sylvain Houle ; Donna E. Stewart ; Nathan J. Kolla ; Stephen Kish ; Lina Chiuccariello ; Jeffrey H. MeyerGreater Monoamine Oxidase A Binding in Perimenopausal Age as Measured With Carbon 11–Labeled Harmine Positron Emission Tomography
000A71 (2014) Nathan J. Kolla ; Lina Chiuccariello ; Alan A. Wilson ; Sylvain Houle ; Paul Links ; R. Michael Bagby ; Shelley Mcmain ; Charis Kellow ; Jalpa Patel ; Paraskevi V. Rekkas ; Suvercha Pasricha ; Jeffrey H. MeyerElevated Monoamine Oxidase-A Distribution Volume in Borderline Personality Disorder Is Associated With Severity Across Mood Symptoms, Suicidality, and Cognition
001116 (2012) Philippe Huot [Canada] ; Tom H. Johnston [Canada] ; Michael N. Gandy [Australie] ; M. Gabriela Reyes [Canada] ; Susan H. Fox [Canada] ; Matthew J. Piggott [Australie] ; Jonathan M. Brotchie [Canada]The Monoamine Re-Uptake Inhibitor UWA-101 Improves Motor Fluctuations in the MPTP-Lesioned Common Marmoset
001685 (2011) Junchao Tong [Canada] ; Isabelle Boileau [Canada] ; Yoshiaki Furukawa [Japon] ; Li-Jan Chang [Canada] ; Alan A. Wilson [Canada] ; Sylvain Houle [Canada] ; Stephen J. Kish [Canada]Distribution of vesicular monoamine transporter 2 protein in human brain: implications for brain imaging studies
001768 (2011) Kandatege Wimalasena [États-Unis]Vesicular monoamine transporters: Structure‐function, pharmacology, and medicinal chemistry
001806 (2011) Neil Vasdev [Canada] ; Oleg Sadovski [Canada] ; Armando Garcia [Canada] ; Frédéric Dollé [France] ; Jeffrey H. Meyer [Canada] ; Sylvain Houle [Canada] ; Alan A. Wilson [Canada]Radiosynthesis of [11C]SL25.1188 via [11C]CO2 fixation for imaging monoamine oxidase B
002179 (2008) Isabelle Boileau [Canada] ; Pablo Rusjan ; Sylvain Houle ; Diana Wilkins ; Junchao Tong ; Peter Selby ; Mark Guttman ; Jean A. Saint-Cyr ; Alan A. Wilson ; Stephen J. KishIncreased vesicular monoamine transporter binding during early abstinence in human methamphetamine users: Is VMAT2 a stable dopamine neuron biomarker?
002676 (2007) Vesna Sossi [Canada] ; James E. Holden [États-Unis] ; Geoffrey J. Topping [Canada] ; Marie-Laure Camborde [Canada] ; Rich A. Kornelsen [Canada] ; Siobhan E. Mccormick [Canada] ; Jennifer Greene [Canada] ; Andrei R. Studenov [Canada] ; Thomas J. Ruth [Canada] ; Doris J. Doudet [Canada]In vivo measurement of density and affinity of the monoamine vesicular transporter in a unilateral 6-hydroxydopamine rat model of PD
002A39 (2005) S. Jourdain [Canada] ; M. Morissette [Canada] ; N. Morin [Canada] ; T. Di Paolo [Canada]Oestrogens Prevent Loss of Dopamine Transporter (DAT) and Vesicular Monoamine Transporter (VMAT2) in Substantia Nigra of 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine Mice
002F24 (2003) Larissa Takser [France] ; Donna Mergler [Canada] ; Georgette Hellier [France] ; Josiane Sahuquillo [France] ; Guy Huel [France]Manganese, monoamine metabolite levels at birth, and child psychomotor development
003315 (2001) Kirk A. Frey [États-Unis] ; Robert A. Koeppe ; Michael R. KilbournImaging the vesicular monoamine transporter
003431 (2000) Marise B. Parent [Canada] ; Marie K. Habib [Canada] ; Glen B. Baker [Canada]Time-dependent changes in brain monoamine oxidase activity and in brain levels of monoamines and amino acids following acute administration of the antidepressant/antipanic drug phenelzine
003453 (2000) Andis Klegeris [Canada] ; Patrick L. Mcgeer [Canada]R -(−)-Deprenyl Inhibits Monocytic THP-1 Cell Neurotoxicity Independently of Monoamine Oxidase Inhibition
003787 (1999) R. L. Sherry [Canada] ; R. T. Coutts [Canada] ; G. B. Baker [Canada]4‐fluorotranylcypromine, a novel monoamine oxidase inhibitor: Neurochemical effects in rat brain after short‐ and long‐term administration
003963 (1998) Saroj K. Chakrabarti [Canada] ; Kovana M. Loua [Canada] ; Chengjiang Bai [Canada] ; Heather Durham [Canada] ; Jean-Claude Panisset [Canada]Modulation of Monoamine Oxidase Activity in Different Brain Regions and Platelets Following Exposure of Rats to Methylmercury
003D02 (1996) W G Tatton [Canada] ; J S Wadia ; W Y Ju ; R M Chalmers-Redman ; N A Tatton(-)-Deprenyl reduces neuronal apoptosis and facilitates neuronal outgrowth by altering protein synthesis without inhibiting monoamine oxidase.
003E90 (1996) W. G. Tatton [Canada] ; R. M. E. Chalmers-Redman [Canada]Modulation of gene expression rather than monoamine oxidase inhibition : (-)-Deprenyl-related compounds in controlling neurodegeneration
003E95 (1996) D. Boismenu [Canada] ; O. Mamer [Canada] ; L. Ste-Marie [Canada] ; L. Vachon [Canada] ; J. Montgomery [Canada]In vivo hydroxylation of the neurotoxin, 1-methyl-4-phenylpyridinium, and the effect of monoamine oxidase inhibitors : Electrospray-MS analysis of intra-striatal microdialysates

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "monoamine" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i  \
                -Sk "monoamine" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Title.i
   |clé=    monoamine
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022